Clinical Trial Update: Exhaled Hydrogen Sulphide as a Biomarker of Airways Disease in Asthma

View source ↗

Summary

A completed clinical trial investigating exhaled hydrogen sulfide as a biomarker for asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: Imperial College London | Conditions: Asthma | Status: COMPLETED | Results posted: 2019-10-21